Active Ingredient(s): Lusutrombopag
FDA Approved: * July 31, 2018
Pharm Company: * SHIONOGI INC

Lusutrombopag, sold under the brand name Mulpleta among others, is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts) such as thrombocytopenia associated with chronic liver disease in patients prior to elective invasive procedures.[1] It is being manufactured and marketed in Japan by Shionogi.[2][3][4] It was approved by the U.S. Food and Drug Administration ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Mulpleta 3 mg Oral Tablet, Film Coated
NDC: 59630-551
Shionogi Inc.